Skip to content

Clinical trials

Phase 3 Myocardial Infarction trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 3 Country / region: United Kingdom Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20052
20062
20082
20091
20102
20113
20135
20141
20181
20191
20201
20211
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated5
Active, not recruiting2
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
AstraZeneca3
NHS Greater Glasgow and Clyde2
Pfizer2
Sanofi2
AtheroGenics1
Bayer1
Boehringer Ingelheim1
CardioKinetix, Inc1
Centocor, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction29
Stroke14
Cardiovascular Diseases10
Heart Failure6
Acute Coronary Syndrome5
Coronary Artery Disease5
Angina, Unstable3
Hyperlipidemias3
Atherosclerosis2
Diabetes Mellitus2

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.